Onset and duration of action of formoterol and tiotropium in patients with moderate COPD

被引：0
|
作者：
Richter, K
Stenglein, S
Muecke, M
Riedinger, F
Sieder, C
Schmidtmann, S
Harnest, U
Magnussen, H
机构：
[1] Pulm Res Inst, Grosshansdorf, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
[3] Pulmol Praxis, Berlin, Germany
来源：
THORAX | 2003年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [41] Early Efficacy Of Budesonide/formoterol In Patients With Moderate, Severe, And Very Severe COPD
    Similowski, T.
    Eriksson, G.
    Postma, D.
    Jenkins, C. R.
    Anzueto, A.
    Make, B. J.
    Fageras, M.
    Persson, A.
    Calverley, P. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [42] Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD
    van Noord, JA
    Aumann, JL
    Janssens, E
    Smeets, JJ
    Verhaert, J
    Disse, B
    Mueller, A
    Cornelissen, PJG
    EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (02) : 214 - 222
  • [43] Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
    Trudo, Frank
    Kern, David M.
    Davis, Jill R.
    Tunceli, Ozgur
    Zhou, Siting
    Graham, Emma L.
    Strange, Charlie
    Williams, Setareh A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 2055 - 2066
  • [44] AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
    Sethi, Sanjay
    Kerwin, Edward
    Watz, Henrik
    Ferguson, Gary T.
    Mroz, Robert M.
    Segarra, Rosa
    Molins, Eduard
    Jarreta, Diana
    Garcia Gil, Esther
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 667 - 682
  • [45] Onset of action of formoterol/budesonide (F/B) Spiromax® compared with F/B Turbuhaler® in patients with COPD: A preliminary report
    Ora, Josuel
    Di Paolo, Alessandra
    Luca, Gabriella
    Calzetta, Luigino
    Rogliani, Paola
    Cazzola, Mario
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [46] Onset of action of formoterol versus salmeterol
    Aalbers, Rene
    van der Woude, Hanneke J.
    RESPIRATORY MEDICINE, 2007, 101 (04) : 871 - 872
  • [47] Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
    Canto, Nivea D.
    Ribeiro, Jorge P.
    Alberto Neder, J.
    Chiappa, Gaspar R.
    RESPIRATORY MEDICINE, 2012, 106 (10) : 1404 - 1412
  • [48] Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries
    Nielsen, Rune
    Kankaanranta, Hannu
    Bjermer, Leif
    Lange, Peter
    Arnetorp, Sofie
    Hedegaard, Morten
    Stenling, Anna
    Mittmann, Nicole
    RESPIRATORY MEDICINE, 2013, 107 (11) : 1709 - 1721
  • [49] The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: A pilot study
    Cazzola, Mario
    Matera, Maria Gabriella
    RESPIRATORY MEDICINE, 2007, 101 (05) : 957 - 962
  • [50] The Influence of Receptor Kinetics on the Onset and Duration of Action and the Therapeutic Index of NVA237 and Tiotropium
    Sykes, David A.
    Dowling, Mark R.
    Leighton-Davies, Juliet
    Kent, Toby C.
    Fawcett, Lindsay
    Renard, Emilie
    Trifilieff, Alexandre
    Charlton, Steven J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 343 (02): : 520 - 528
12345